Answers are grounded in this paper and cite their sources.
Staphylococcus aureus continues to pose a major threat to public health and is responsible for 20,000 deaths each year in the US [1].The problem is exacerbated by methicillin-resistant S. aureus (MRSA) which, according to the World Health Organisation's 2014 Antimicrobial Resistance Global Report on Surveillance is associated with a >60% increase in mortality compared to antibiotic susceptible S. aureus.Membrane transport systems can control both virulence and antibiotic resistance and represent novel targets for therapeutic agents.Here we discuss how efforts to overcome antimicrobial drug resistance could include novel agents targeting important metabolic processes dependent on membrane transporters, which have the potential to augment existing antibiotics. Why investigate amino acid and peptide transporters as potential therapeutic targets?Amino acids are essential for sustaining cell integrity and metabolic homeostasis.In addition to protein synthesis, amino acids are also precursors for biosynthesis of nucleotides, lipids and cell wall components.S. aureus can synthesize many of these amino acids but will often preferentially transport them into the cell from the external environment [2].Limited glucose availability (for example in an abscess) represents an environment in which catabolism of peptides or amino acids is important for S. aureus growth [3].Bioinformatic analysis reveals several pathways that enable S. aureus to catabolize multiple amino acids, which in turn can generate key central metabolic intermediates such as pyruvate, oxaloacetate and 2-oxoglutarate.Reflecting this importance of amino acids in metabolism, S. aureus has multiple oligopeptide permeases, free amino acid transporters and proteases to degrade host proteins.An analysis of 64 S. aureus strains revealed that amino acid metabolism genes are disproportionately associated with the pangenome [4] indicating that targeting transporters associated with core amino acid metabolism is likely to have broader therapeutic potential against diverse S. aureus isolates.The diversity and redundancy of amino acid, peptide, osmolyte and nucleoside uptake systems also presents a significant challenge.There are at least 292 genes in the USA300_FPR3757 genome predicted to encode membrane transporters, of which 120 appear to be associated with amino acid, osmolyte or nucleoside transport.Bioinformatic tools are generally helpful in identifying and predicting the functions of putative transporters, but experimental work is required to verify the substrates transported by permeases and their physiological roles.
No takes yet. Share an insight, caveat, or question.
Zeden et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: